LIGAND PHARMACEUTICALS INCORPORATED Debt Securities, Available-for-sale, Allowance for Credit Loss
LIGAND PHARMACEUTICALS INCORPORATED (LGNZZ) had Debt Securities, Available-for-sale, Allowance for Credit Loss of $0 as of 2024-06-30, per its 10-Q filed 2024-08-07.
Discontinued › Notes › Credit Losses
us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss · last filed 2024-08-07
- 2024-06-30: Debt Securities, Available-for-sale, Allowance for Credit Loss $0.00.
- 2024-03-31: Debt Securities, Available-for-sale, Allowance for Credit Loss $0.00.
- 2023-09-30: Debt Securities, Available-for-sale, Allowance for Credit Loss $0.00.
- 2023-06-30: Debt Securities, Available-for-sale, Allowance for Credit Loss $0.00.
| Period end | Debt Securities, Available-for-sale, Allowance for Credit Loss |
|---|---|
| 2024-06-30 | $0.00 10-Q · filed 2024-08-07 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-08 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-09 |
| 2023-06-30 | $0.00 10-Q · filed 2024-08-07 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-08 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-08 |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-09 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-09 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-09 |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-03 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-06 |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-06 |
| 2020-06-30 | $0.00 10-Q · filed 2020-08-07 |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-08 |